HomeHealth articlesheart diseaseWhat Is Barth Syndrome?

Barth Syndrome: A Rare Genetic Disorder of Heart

Verified dataVerified data
0

4 min read

Share

Barth syndrome is a rare genetic condition that causes decreased cardiac function. This article reviews the causes, symptoms, and treatment of the disease.

Medically reviewed by

Dr. Kaushal Bhavsar

Published At December 20, 2022
Reviewed AtMarch 7, 2023

Introduction:

Barth syndrome is a genetic condition characterized by an enlarged and weakened heart. It is a rare condition that primarily affects men. It usually presents as a congenital disability or develops within the first months of life. As it progresses, the heart becomes weaker and unable to pump blood. It is also called:

  • X-linked endocardial fibroelastosis.

  • 3-methylglutaconic aciduria.

  • X-linked cardioskeletal myopathy and neutropenia.

  • Cardioskeletal myopathy with neutropenia and abnormal mitochondria.

  • Endocardial fibroelastosis.

What Are the Clinical Features?

Barth Syndrome almost exclusively affects men. It is a very rare condition and is estimated to affect 1 in 300,000 to 400,000 individuals globally. Some of the symptoms include:

  • Enlarged heart or dilated cardiomyopathy).

  • Weakened heart.

  • A low white blood cell count-neutropenia.

  • Fatigue.

  • Weakness of muscle used for movement- skeletal myopathy.

  • Short stature.

  • Distinct facial features such as prominent cheeks.

How Does the Disease Progress?

  • Patients affected have elastic fibers in place of muscle fibers in some areas of the heart. This leads to cardiomyopathy and is called endocardial fibroelastosis. This leads to the thickening of the muscles and impairs the heart from pumping blood. In the majority of cases, these problems lead to heart failure. In some cases, it resolves over time, and the individuals have no symptoms of a heart condition.

  • Muscles present close to the body become weak and low in tone (hypotonia). This is noticeable from birth, and this leads to the delay of motor skills such as walking and crawling. These individuals also experience extreme fatigue if subjected to strenuous exercise or physical activity.

  • These individuals have normal intelligence but may find difficulty in solving tasks involving math and visual-spatial skills, such as puzzles.

  • They have prominent cheeks and distinctive facial features.

  • Blood and urine samples of affected males have increased levels of 3-methylglutaconic acid. This helps in diagnosing the disease but does not influence the condition.

  • The affected males have reduced life expectancy. The affected children can die of heart failure or infections in infancy or early childhood. Those children who live into adulthood can survive up to their late forties. Cardiac muscle weakness leads to heart failure, and the reduced number of white blood cells makes the individual susceptible to infections.

  • Even though the clinical features are distinctive and can be recognized at birth or infancy, the individuals may not experience health problems until later in life. And because of this, individuals with Barth syndrome may not be diagnosed early, and the severity of signs and symptoms may vary greatly.

How Is It Inherited?

  • The cause of Barth syndrome is the mutation in a specific gene called Tafazzin. The gene associated with the condition is located on the X-chromosomes (one of the sex chromosomes); therefore, the condition mostly affects men. That is, the syndrome is inherited in an X-linked recessive pattern.

  • If the affected copy of the gene is passed on to the male child, they are affected (since men have only one copy of the X-chromosome). Whereas in females, both copies of the chromosome should be affected for the disease to be expressed. If only one chromosome is affected, then they become carriers. Because the probability of women having two affected genes is low, the disease is rarely found in women.

  • Another interesting characteristic is that the fathers will not pass the trait to their sons but will pass the abnormal gene to all their daughters, who will be carriers. Whereas if the mother is a carrier, there is a 25 % chance that the male child will inherit the X-chromosome that contains the abnormal gene; if so, he will develop the disease. Carrier females have a 25 % chance of having a carrier daughter, a noncarrier daughter, an unaffected son, and an affected son with each pregnancy.

  • Tafazzin is responsible for altering a fat called cardiolipin which is found in mitochondria, which in turn is responsible for energy production needed for an organ. Therefore it is believed that loss of this gene affects the energy production in organs such as the heart and skeletal muscles leading to the condition.

How to Diagnose Barth Syndrome?

Barth syndrome is usually diagnosed during infancy or early childhood. But in some cases, the severity of symptoms varies; hence may be diagnosed later in life.

It is diagnosed based on clinical evaluation, detailed family history (since it can be inherited), physical findings, and specialized tests.

Barth syndrome can be suspected if someone has the following:

  • Heart conditions such as hypertrophic cardiomyopathy and dilated cardiomyopathy.

  • Increased levels of 3-methylglutaconic acid in urine or blood.

  • Neutropenia- low white blood cell count.

  • Hypotonia.

  • Delay in milestones in infants, such as crawling and walking.

  • Delay in growth.

  • Multiple losses of pregnancies have been reported in some families with Barth syndrome involving male fetuses.

For confirmation of the disease, molecular genetic testing can be done.

How Is Barth Syndrome Treated?

Since it is a genetic condition, the treatment is based on the symptoms. And as the symptoms vary, it requires an interdisciplinary approach, including pediatricians, cardiologists that specialize in childhood heart disease, hematologists (to study the blood cells and tissues), and specialists to treat infections.

  • Heart conditions may be treated with standard cardiac medications such as beta blockers, Digoxin, and ACE inhibitors. This helps to improve heart function and also reduces the risk of heart failure. A low dose of Aspirin is given to prevent clot formation. In severe cases, a heart transplant may be necessary. In some cases, the heart function improves after infancy, so transplant must be only considered in severe cases.

  • For patients who have low white blood cell count and an increased tendency for bacterial infection, regular monitoring is required. If an infection is suspected, antibiotic therapy should be started early. In some cases, prophylactic (as preventive) antibiotics may be given.

  • Physical therapy from early stages can help improve muscle tone and thereby help the child in attaining developmental milestones. Uncooked cornstarch before bedtime may help prevent muscle loss.

  • If Barth syndrome is in the family, genetic counseling is recommended. If an individual is affected, the treatment is supportive and based on the symptoms.

Conclusion:

Barth syndrome is a rare genetic condition that mainly affects men. Affected individuals have poor muscle tone and decreased cardiac activity. The symptoms may start in infancy and may obstruct developmental milestones. The individuals may be easily fatigued, and heart conditions may progress to heart failure. The reduction in white blood cells makes them prone to infections. Genetic counseling may be required for families with a history of Barth syndrome. Diagnosis and treatment are based on symptoms.

Frequently Asked Questions

1.

What Is the Lifespan of Barth Syndrome?

Barth syndrome is a rare genetic disorder caused due to gene mutations. The lifespan of the individuals varies depending on the symptoms' severity or management of their health. The condition is associated with several heart disorders, such as muscle weakness, weakened heart muscle, or fatigue. If an individual has symptoms such as heart failure, it can reduce the life span. The average life span is around 30 to 40 years.

2.

Which Enzyme Is Lacking in Barth Syndrome?

The enzyme deficient in Barth syndrome is tafazzin, encoded as the TAZ gene. The enzyme is involved in cardiolipin remodeling. It is a type of phospholipid present in the cells' inner mitochondrial membrane. The enzyme adds unsaturated fatty acids to cardiolipin, which is essential for the structure and function of mitochondria. Mutation in the TAZ gene can lead to an abnormal cardiolipin profile and impair mitochondrial function.

3.

What Are the Clinical Features of the Face of Barth Syndrome?

The facial features are as follows:
- Narrow face.
- A small chin.
- Prominent ears.
- Deep-set eyes.
- A small mouth.
- Thin upper lip.
- Broad nasal bridge.

4.

Can Barth Syndrome Be Treated?

Barth syndrome has no cure. The symptoms can be managed through treatment or therapies. 
 
The common treatment is as follows:
- Medications: The doctor may prescribe angiotensin-converting enzyme (ACE) inhibitors to improve heart function. Antibiotics are prescribed to treat infections. 
- Physical Therapy: The therapy is prescribed to manage muscle weakness. The doctor may prescribe exercise or stretches to maintain strength and flexibility.
- Nutritional Support: The doctor may advise the patient to take caloric and nutritional food. 
- Genetic Counselling: The counseling may provide information about the condition.
 

5.

Can Women Have Barth Syndrome?

 
The TAZ gene mutation causes Barth syndrome. This gene is located on the X chromosome. Males have one X and one Y chromosome. Females have two X chromosomes, so they have one extra X chromosome, which can compensate for the mutations. Rarely do females have Barth syndrome. Females with the syndrome show milder symptoms.

6.

Who Identified the Barth Syndrome?

Barth syndrome was discovered by Dr. Peter Barth, a pediatric cardiologist, in 1983. Dr. Barth observed a group of males with a heart muscle disease and found common clinical features such as delay in growth, skeletal muscle weakness, and low levels of neutrophils.

7.

What Genetic Test Is Used to Diagnose Barth Syndrome?

The genetic tests used to diagnose Barth syndrome are as follows:
- Sanger Sequencing: The method of deoxyribulose (DNA) sequencing. It is used to identify the TAG gene mutations. 
- Multiple Ligation-Dependent Probe Amplification: The technique detects deletions and duplication in the TAZ gene.
- Targeted Gene Panels: It is used to detect gene mutations.

8.

At What Age Does Barth Syndrome Present?

Barth syndrome is present at birth. In some people, symptoms may appear later in life, during infancy or childhood. Males are more commonly affected than females. Females are less likely to develop the condition. Some infants show symptoms immediately after birth, and some do not show until later in childhood.

9.

What Are the Signs and Symptoms of Barth Syndrome?

The signs and symptoms are as follows:
- Muscle weakness or fatigue.
- Growth delay.
- Some infants may have feeding difficulties.
- Delayed speech development.
- Thrombocytopenia (decrease in number of platelets).
- Neutropenia (decrease in number of neutrophils and increase the chances of infection).
- Cardiomyopathy (heart enlargement).

10.

What Are the Physical Features of Barth Syndrome?

The physical features are as follows:
- Muscle weakness.
- Low muscle mass.
- Joint hypermobility.
- Low body weight.
- Growth and development delay.

11.

What Is the Cardiolipin Test Used to Diagnose Barth Syndrome?

The cardiolipin test is a type of blood test used to diagnose Barth syndrome. Cardiolipin is a type of fat found in the inner membrane of mitochondria. The TAZ gene is responsible for modifying cardiolipin. The cardiolipin test measures the levels of cardiolipin in the body.
Dr. Kaushal Bhavsar
Dr. Kaushal Bhavsar

Pulmonology (Asthma Doctors)

Tags:

heart diseasebarth syndrome
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

heart disease

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy